Chapter 5. Nuclear Membrane Protein Emerin: Roles in Gene Regulation, Actin Dynamics and Human Disease
- Derek J. Chadwick Organizer,
- Jamie Goode
Published Online: 7 OCT 2008
DOI: 10.1002/0470093765.ch5
Copyright © Novartis Foundation 2005
Book Title

Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264
Additional Information
How to Cite
Wilson, K. L., Holaska, J. M., de Oca, R. M., Tifft, K., Zastrow, M., Segura-Totten, M., Mansharamani, M. and Bengtsson, L. (2008) Nuclear Membrane Protein Emerin: Roles in Gene Regulation, Actin Dynamics and Human Disease, in Nuclear Organization in Development and Disease: Novartis Foundation Symposium 264 (eds D. J. Chadwick and J. Goode), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470093765.ch5
Publication History
- Published Online: 7 OCT 2008
- Published Print: 14 JAN 2005
ISBN Information
Print ISBN: 9780470093733
Online ISBN: 9780470093764
- Summary
- Chapter
Keywords:
- Emery-Dreifuss muscular dystrophy (EDMD);
- barrier-to-autointegration factor (BAF);
- lamin polymer configuration;
- emerin and A-type lamins;
- ‘tissue-specific interactor’ model;
- S54F disease-causing missense mutation;
- gene regulatory complexes;
- lamin-binding nuclear membrane proteins;
- nuclear lamina infrastructure
Summary
Loss of emerin, a nuclear membrane protein, causes Emery-Dreifuss muscular dystrophy (EDMD), characterized by muscle weakening, contractures of major tendons and potentially lethal cardiac conduction system defects. Emerin has a LEM-domain and therefore binds barrier-to-autointegration factor (BAF), a conserved chromatin protein essential for cell division. BAF recruits emerin to chromatin and regulates higher-order chromatin structure during nuclear assembly. Emerin also binds filaments formed by Atype lamins, mutations in which also cause EDMD. Other partners for emerin include nesprin-1a and transcriptional regulators such as germ cell-less (GCL). The binding affinities of these partners range from 4 nM (nesprin-1α) to 200nM (BAF), and are physiologically significant. Biochemical studies therefore provide a valid means to predict the properties of emerin–lamin complexes in vivo. Emerin and lamin A together form stable complexes with either BAF or GCL in vitro. BAF, however, competes with GCL for binding to emerin in vitro. These and additional partners, notably actin and nuclear myosin I, suggest disease-relevant roles for emerin in gene regulation and the mechanical integrity of the nucleus.
